Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_assertion type Assertion NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_head.
- NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_assertion description "[The genes E-cadherin (ECAD), transmembrane protein with epidermal growth factor-like and 2 follistatin-like domains 2 (TMEFF2), retinoic acid receptor beta (RAR?), and O-6 methylguanine DNA methyltransferase (MGMT) had high sensitivity (>75%) and specificity for the detection of oral cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.
- NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_assertion evidence source_evidence_literature NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.
- NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_assertion SIO_000772 22252571 NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.
- NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_assertion wasDerivedFrom befree-20140225 NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.
- NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_assertion wasGeneratedBy ECO_0000203 NP468077.RAqyCACeL1mN54OH2uoqhXOrGHo6xWJjWXlMWUVBx_BoY130_provenance.